![Determining the Standard of Review for Claim Construction: Supreme Court Holds Oral Argument for Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. | S.J. Quinney College of Law Determining the Standard of Review for Claim Construction: Supreme Court Holds Oral Argument for Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. | S.J. Quinney College of Law](https://i1.wp.com/law.utah.edu/wp-content/uploads/2014/10/Austen-Paulsen-.jpg?fit=239%2C300&ssl=1)
Determining the Standard of Review for Claim Construction: Supreme Court Holds Oral Argument for Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. | S.J. Quinney College of Law
![Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal](https://media.bizj.us/view/img/10278469/unknown-6*1200xx2016-1136-0-122.jpg)
Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal
![Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN](https://dynaimage.cdn.cnn.com/cnn/c_fill,g_auto,w_1200,h_675,ar_16:9/https%3A%2F%2Fcdn.cnn.com%2Fcnnnext%2Fdam%2Fassets%2F211230154406-teva-pharmaceuticals-file-2021.jpg)
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
![Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business](https://media.cnn.com/api/v1/images/stellar/prod/230821162715-teva-pharmaceuticals-file-restricted.jpg?c=16x9&q=h_720,w_1280,c_fill)
Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business
![Attorney Carter G. Phillips, representing generic drug maker Mylan Pharmaceuticals, departs the Supreme Court in Washington, Wednesday, Oct. 15, 2014, after arguments in Teva Pharmaceuticals U.S.A., Inc. v. Sandoz, Inc. Justices seem Attorney Carter G. Phillips, representing generic drug maker Mylan Pharmaceuticals, departs the Supreme Court in Washington, Wednesday, Oct. 15, 2014, after arguments in Teva Pharmaceuticals U.S.A., Inc. v. Sandoz, Inc. Justices seem](https://c8.alamy.com/comp/2N3T00B/attorney-carter-g-phillips-representing-generic-drug-maker-mylan-pharmaceuticals-departs-the-supreme-court-in-washington-wednesday-oct-15-2014-after-arguments-in-teva-pharmaceuticals-usa-inc-v-sandoz-inc-justices-seem-divided-as-it-considers-a-high-stakes-patent-dispute-between-rival-pharmaceutical-companies-over-the-worlds-best-selling-multiple-sclerosis-treatment-a-case-that-threatens-to-cut-into-the-4-billion-a-year-profits-that-israel-based-teva-pharmaceutical-industries-ltd-earns-selling-the-drug-copaxone-teva-claims-the-us-court-of-appeals-for-the-federal-circuit-w-2N3T00B.jpg)